---
title: Raybow Pharmaceutical
description: "Raybow Pharmaceutical, a fine chemicals manufacturer integrating green chemistry and CDP-driven insights to improve process efficiency and resource performance."
locale: ja
canonical: https://www.cdp.net/ja/insights/raybow-pharmaceutical
contentType: insightPage
updatedAt: 2026-08-12T14:08:40.285Z
---

Raybow Pharmaceutical, a fine chemicals manufacturer integrating green chemistry and CDP-driven insights to improve process efficiency and resource performance.

![Raybow logo](https://images.ctfassets.net/v7uy4j80khf8/34iMdTFg8kvJSUY7R7aXTV/e5621bdcb307d04274aedacbc75dac39/Raybow_logo.png?w=800&fm=webp&q=80&f=center)

Raybow Pharmaceutical has demonstrated how environmental disclosure can drive measurable gains in operational efficiency. In 2025, the company **achieved a CDP A score in water security through implementing advanced green chemistry capabilities.**

Driven by rising customer expectations on environmental performance, the company has embedded climate, water and emissions management into its core operations—**integrating sustainability directly into day-to-day decision-making and execution.**

**   **

### Translating disclosure into action

- **Raybow has aligned site-level implementation** with its parent company’s ESG governance framework and the CDP disclosure framework, enabling coordinated action across Environment, Health, and Safety practices, production, procurement and engineering teams. 
- **A dedicated CDP working group standardizes** data boundaries, improves data consistency and strengthens internal accountability. 
- **The company uses CDP disclosure to** identify gaps in energy use, waste and resource efficiency—translating insights into targeted improvement projects.

   

### Driving measurable impact

- Through process innovation, including continuous flow chemistry, the company has reduced energy consumption, processing time and waste generation, while improving product yield.
- It has applied green chemistry and biotechnology solutions, supported by a microbial strain library of 900+ strains across 20+ process pathways, enabling scalable low-impact production.
- Equipment upgrades and enhanced metering systems have improved resource efficiency and data accuracy, supporting ongoing optimization.

Raybow Pharmaceutical’s experience highlights how **structured environmental disclosure can strengthen operational discipline**, helping translate environmental data into better process design, resource management and production performance.

## Explore more case studies

Discover how organizations are benefiting by disclosing through CDP. Browse our full selection of disclosure-related case studies.

**Browse case studies****Visit Disclosure Hub**